Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12674)

• Formulation Name: Loxapine 5 mg capsule
• Company: Actavis Pharma; Carilion Materials Management; Clinical Solutions Wholesale; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Loxapine	(DM8AI9U)	Bipolar disorder	6A60	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Benzyl alcohol	(E00010)	244	Antimicrobial preservative; Solvent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylparaben	(E00142)	7184	Antimicrobial preservative
Edetate calcium disodium	(E00487)	6093170	Complexing agent
Magnesium stearate	(E00208)	11177	lubricant
methylparaben	(E00149)	7456	Antimicrobial preservative
Propyl 4-hydroxybenzoate	(E00141)	7175	Antimicrobial preservative
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sodium propionate	(E00445)	2723816	Antimicrobial preservative
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent